CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,240,349 | +47.1% | 83,189 | +8.1% | 0.00% | – |
| Q2 2023 | $843,244 | +164.3% | 76,957 | +110.4% | 0.00% | – |
| Q1 2023 | $319,022 | +1287.1% | 36,585 | +401.0% | 0.00% | – |
| Q1 2022 | $23,000 | +21.1% | 7,302 | +31.4% | 0.00% | – |
| Q4 2021 | $19,000 | -5.0% | 5,558 | 0.0% | 0.00% | – |
| Q3 2021 | $20,000 | -16.7% | 5,558 | 0.0% | 0.00% | – |
| Q2 2021 | $24,000 | -44.2% | 5,558 | -41.2% | 0.00% | – |
| Q1 2021 | $43,000 | -20.4% | 9,457 | 0.0% | 0.00% | – |
| Q4 2020 | $54,000 | +22.7% | 9,457 | +54.9% | 0.00% | – |
| Q3 2020 | $44,000 | +46.7% | 6,106 | -28.2% | 0.00% | – |
| Q2 2020 | $30,000 | +50.0% | 8,503 | -36.7% | 0.00% | – |
| Q1 2020 | $20,000 | -37.5% | 13,434 | -18.1% | 0.00% | – |
| Q4 2019 | $32,000 | -54.9% | 16,404 | +19.3% | 0.00% | – |
| Q3 2019 | $71,000 | -27.6% | 13,746 | 0.0% | 0.00% | – |
| Q2 2019 | $98,000 | -30.0% | 13,746 | +29.7% | 0.00% | – |
| Q1 2019 | $140,000 | +79.5% | 10,595 | +6.6% | 0.00% | – |
| Q4 2018 | $78,000 | -29.1% | 9,941 | 0.0% | 0.00% | – |
| Q3 2018 | $110,000 | -17.9% | 9,941 | 0.0% | 0.00% | – |
| Q2 2018 | $134,000 | – | 9,941 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
| COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
| Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
| Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
| Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
| Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
| ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
| CM Management, LLC | 150,000 | $681,000 | 0.51% |
| APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
| Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |